Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Affodapa M 10/500 Tablet ER

Prescription Icon
Prescription Required

Marketer

Medicamen Lifesciences Pvt Ltd

Salt Composition

Dapagliflozin (10mg) + Metformin (500mg)

Overview Affodapa M 10/500 Tablet ER

DiabetaComb ER 10/500 tablets combine two medications to manage type 2 diabetes, effectively lowering elevated blood glucose. This helps mitigate the risk of serious diabetic complications, including cardiovascular disease. DiabetaComb ER 10/500 can be taken with food, consistently at the same time daily to aid adherence. Dosage is determined by your physician; discontinue use only under medical supervision, as abrupt cessation may elevate blood sugar, potentially causing kidney damage or vision loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight control as recommended by your doctor. Common side effects include headache, nausea, vomiting, diarrhea, nasal congestion, sore throat, and runny nose. Adequate hydration is crucial to avoid dehydration. Genital fungal infections may occur; diligent hygiene can help minimize this risk. Prior to commencing treatment, discuss any kidney or liver issues, urinary tract infections, diuretic use, or pregnancy/breastfeeding with your doctor. Limit alcohol consumption, as it might exacerbate side effects. Regular blood glucose monitoring is essential during treatment.

Primary Ingredients of Affodapa M 10/500 Tablet ER

No information provided. Please provide the text you wish to be rewritten.

Uses of Affodapa M 10/500 Tablet ER

Managing type 2 diabetes

Major Benefits of Affodapa M 10/500 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Affodapa M 10/500 Extended-Release tablets should be administered with a meal.

Common Side effects of Affodapa M 10/500 Tablet ER:

  • Nausea
  • Vomiting
  • Diarrhea
  • Genital fungal infection
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Urinary tract infection
  • Polyuria
  • Flatulence
  • Skin rash
  • Taste change
  • Difficulty in urination
  • Hypoglycemia (low blood glucose level)
  • Tremors
  • Dizziness
  • Back pain
  • Increased hematocrit
  • Decreased creatinine clearance
  • Dyslipidemia

How to use Affodapa M 10/500 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Affodapa M 10/500 Tablet ER whole; avoid crushing, chewing, or breaking it. Administer this extended-release tablet with a meal.

How Affodapa M 10/500 Tablet ER works:

Affodapa M 10/500 Extended-Release tablets combine dapagliflozin and metformin to manage type 2 diabetes. Dapagliflozin helps eliminate excess glucose via urinary excretion, while metformin reduces hepatic glucose production, slows intestinal glucose uptake, and enhances insulin responsiveness. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Affodapa M 10/500 Tablet ER is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Affodapa M 10/500 tablet might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Affodapa M 10/500 Tablet likely poses a risk during lactation. Available evidence from human studies indicates potential transfer to breast milk, posing a possible threat to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Affodapa M 10/500 Extended-Release tablets. Dosage modification may be necessary; physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when using Affodapa M 10/500 Extended-Release tablets. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Affodapa M 10/500 Tablet ER :

Should you forget a dose of Affodapa M 10/500 Tablet ER, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Affodapa M 10/500 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
Affodapa M 10/500 Tablet ...
89
MRP 103
13% off